Adaptyx Biosciences
Adaptyx Biosciences is developing a wearable platform for continuous monitoring of multiple biomarkers in dermal interstitial fluid from a single device at the point of need. Built on programmable molecular switch technology that can be reprogrammed across hormones, drugs, electrolytes, peptides, and proteins, it is a single platform adaptable to needs spanning Military Operational Medicine, Combat Casualty Care, Military Infectious Diseases, Clinical and Rehabilitative Medicine, and Chemical, Biological, and Radiological Defense. The platform draws on more than 17 years of pioneering research from our team at Stanford. We have prototype sensors ready for R&D today, and have already demonstrated continuous measurement of multiple biomarkers in humans, including multi-day free cortisol monitoring that captures the diurnal rhythm conventional single-timepoint tests cannot see.
Industries
Patents
Products
A minimally-invasive wearable device integrating programmable chemistry, electronics, and AI-driven analytics to continuously collect, analyze, and transmit multi-analyte molecular data from interstitial fluid.
A minimally-invasive wearable device integrating programmable chemistry, electronics, and AI-driven analytics to continuously collect, analyze, and transmit multi-analyte molecular data from interstitial fluid.
Expertise Areas
- Continuous molecular monitoring
- Biosensor engineering
- Digital health data integration
- Clinical biomarker application
Key Technologies
- Programmable molecular switches
- Synthetic DNA-based biosensor architectures
- Minimally-invasive dermal probes
- High-throughput biomolecular screening
Key People
Co-Founder & Scientific Advisor
Co-Founder & Scientific Advisor
Co-Founder & Scientific Advisor
Co-Founder & Scientific Advisor